Journal Mobile Options
Table of Contents
Vol. 71, No. 1, 2005
Issue release date: 2005
Digestion 2005;71:29–30
(DOI:10.1159/000083869)

Obstructive Fibrostenotic Crohn’s Disease

Froehlich F. · Juillerat P. · Mottet C. · Felley C. · Vader J.-P. · Burnand B. · Gonvers J.-J. · Michetti P.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Crohn’s disease is often complicated by gastrointestinal strictures. Postoperative recurrence at the anastomotic site is common and repeated surgical interventions may be necessary. Medical treatment may relieve active inflammation (see chapter on active luminal disease) but fibrous strictures will not respond to this. Mechanical treatment methods consist of endoscopic balloon dilation, stricturoplasty or surgical resection. Fibrostenotic Crohn’s disease does not respond to medical therapy and requires endoscopic or surgical treatment.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Legnani PE, Kornbluth A: Therapeutic options in the management of strictures in Crohn’s disease. Gastrointest Endosc Clin N Am 2002;12:589–603.
  2. Sandborn WJ, et al: A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease. Gastroenterology 2002;122:512–530.
  3. Sands BE: Crohn’s Disease. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, ed 7. New York, Elsevier, 2002, pp 2005–2038.
  4. Fazio VW, et al: Effect of resection margins on the recurrence of Crohn’s disease in the small bowel. A randomized controlled trial. Ann Surg 1996;224:563–573.
  5. Thirlby RC, et al: Effect of surgery on health-related quality of life in patients with inflammatory bowel disease: A prospective study. Arch Surg 1998;133:826–832.
  6. Fazio VW, et al: Long-term follow-up of strictureplasty in Crohn’s disease. Dis Colon Rectum 1993;36:355–361.
  7. Dietz DW, et al: Safety and long-term efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn’s disease. J Am Coll Surg 2001;192:330–338.
  8. Sayfan J, et al: Recurrence after strictureplasty or resection for Crohn’s disease. Br J Surg 1989;76:335–338.
  9. Cristaldi M, et al: Long-term results and multivariate analysis of prognostic factors in 138 consecutive patients operated on for Crohn’s disease using ‘bowel-sparing’ techniques. Am J Surg 2000;179:266–270.
  10. Couckuyt H, et al: Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn’s strictures: A prospective long-term analysis. Gut 1995;36:577–580.
  11. Dear KL, Hunter JO: Colonoscopic hydrostatic balloon dilatation of Crohn’s strictures. J Clin Gastroenterol 2001;33:315–318.
  12. Thomas-Gibson S, et al: Colonoscopic balloon dilation of Crohn’s strictures: A review of long-term outcomes. Eur J Gastroenterol Hepatol 2003;15:485–488.


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00